The perioperative outcomes of uniportal robotic-assisted thoracic surgeries-a systematic review and meta-analysis of surgical cohort studies and case reports.
Robotic thoracic surgery
early outcomes
lobectomy
wedge resection
Journal
Annals of cardiothoracic surgery
ISSN: 2225-319X
Titre abrégé: Ann Cardiothorac Surg
Pays: China
ID NLM: 101605877
Informations de publication
Date de publication:
31 Mar 2023
31 Mar 2023
Historique:
received:
10
03
2023
accepted:
27
03
2023
accepted:
30
03
2023
medline:
11
4
2023
entrez:
10
4
2023
pubmed:
11
4
2023
Statut:
ppublish
Résumé
Early results have illustrated the multiportal robotic approach to be safe and oncologically efficacious in the treatment of thoracic malignancies. Industry leaders have improved upon the lessons learned during the early multiportal studies and have now come to establish the feasibility of the biportal, and subsequently the uniportal robotic-assisted approach, all in an effort to offer patients equivalent or better outcomes with less surgical trauma. No current, coherent body of evidence currently exists outlining the early-term outcomes of patients undergoing uniportal robotic-assisted thoracic surgery. This systematic review and meta-analysis sought to clarify the early-phase outcomes of these patients. An electronic search of four databases was performed to identify relevant studies outlining the immediate post-operative outcomes of patients undergoing uniportal robotic-assisted thoracic surgeries. The primary endpoint was defined as technical success (i.e., no conversion to secondary robotic, video-assisted thoracoscopic, or open approaches). Secondary endpoints of interest included post-operative outcomes and complication rates. A meta-analysis using a random effects model of proportions or means was applied, as appropriate. The search strategy ultimately yielded 12 relevant studies for inclusion. A total of 240 patients (52% male) split across cohort studies and case reports were identified. The mean age of the two groups was 59.7±3.0 and 58.1±6.8 years, respectively. The mean operative time was 133.8±38.2 and 150.0±52.2 minutes, respectively. Length of hospital stay was 4.4±1.6 and 4.3±1.1 days, respectively. The mean blood loss was 80.0±25.1 mL The majority of identified procedures were lobectomies, segmentectomies, and wedge resections, though complex sleeve resections and anterior mediastinal mass resections were also completed. Cumulative technical success was 99.9%. The uniportal robotic-assisted approach, when completed in expert hands, has been illustrated to have exceedingly low rates of conversion to secondary procedures, along with short length of stay (LOS), minimal blood loss, and short procedural times (variable depending on operation type). Current evidence on the feasibility of this approach will be bolstered by upcoming multi-institutional series.
Sections du résumé
Background
UNASSIGNED
Early results have illustrated the multiportal robotic approach to be safe and oncologically efficacious in the treatment of thoracic malignancies. Industry leaders have improved upon the lessons learned during the early multiportal studies and have now come to establish the feasibility of the biportal, and subsequently the uniportal robotic-assisted approach, all in an effort to offer patients equivalent or better outcomes with less surgical trauma. No current, coherent body of evidence currently exists outlining the early-term outcomes of patients undergoing uniportal robotic-assisted thoracic surgery. This systematic review and meta-analysis sought to clarify the early-phase outcomes of these patients.
Methods
UNASSIGNED
An electronic search of four databases was performed to identify relevant studies outlining the immediate post-operative outcomes of patients undergoing uniportal robotic-assisted thoracic surgeries. The primary endpoint was defined as technical success (i.e., no conversion to secondary robotic, video-assisted thoracoscopic, or open approaches). Secondary endpoints of interest included post-operative outcomes and complication rates. A meta-analysis using a random effects model of proportions or means was applied, as appropriate.
Results
UNASSIGNED
The search strategy ultimately yielded 12 relevant studies for inclusion. A total of 240 patients (52% male) split across cohort studies and case reports were identified. The mean age of the two groups was 59.7±3.0 and 58.1±6.8 years, respectively. The mean operative time was 133.8±38.2 and 150.0±52.2 minutes, respectively. Length of hospital stay was 4.4±1.6 and 4.3±1.1 days, respectively. The mean blood loss was 80.0±25.1 mL The majority of identified procedures were lobectomies, segmentectomies, and wedge resections, though complex sleeve resections and anterior mediastinal mass resections were also completed. Cumulative technical success was 99.9%.
Conclusions
UNASSIGNED
The uniportal robotic-assisted approach, when completed in expert hands, has been illustrated to have exceedingly low rates of conversion to secondary procedures, along with short length of stay (LOS), minimal blood loss, and short procedural times (variable depending on operation type). Current evidence on the feasibility of this approach will be bolstered by upcoming multi-institutional series.
Identifiants
pubmed: 37035647
doi: 10.21037/acs-2023-urats-37
pii: acs-12-02-73
pmc: PMC10080331
doi:
Types de publication
Journal Article
Langues
eng
Pagination
73-81Informations de copyright
2023 Annals of Cardiothoracic Surgery. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: The authors have no conflicts of interest to declare.
Références
BMC Med Res Methodol. 2014 Dec 19;14:135
pubmed: 25524443
Ann Cardiothorac Surg. 2023 Jan 31;12(1):23-33
pubmed: 36793982
Front Surg. 2022 Oct 31;9:1043374
pubmed: 36386512
Ann Cardiothorac Surg. 2023 Jan 31;12(1):34-40
pubmed: 36793988
Transl Lung Cancer Res. 2021 Mar;10(3):1571-1575
pubmed: 33889530
Ann Cardiothorac Surg. 2023 Jan 31;12(1):62-63
pubmed: 36793986
Kardiochir Torakochirurgia Pol. 2022 Sep;19(3):146-151
pubmed: 36268481
Kardiochir Torakochirurgia Pol. 2022 Dec;19(4):240-242
pubmed: 36643352
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Front Surg. 2022 Sep 23;9:1005860
pubmed: 36329983
World J Urol. 2020 Apr;38(4):897-905
pubmed: 31463560
Ann Cardiothorac Surg. 2023 Jan 31;12(1):1-8
pubmed: 36793987
Ann Cardiothorac Surg. 2023 Jan 31;12(1):64-66
pubmed: 36793983
Ann Cardiothorac Surg. 2023 Jan 31;12(1):52-61
pubmed: 36793991
Ann Cardiothorac Surg. 2023 Jan 31;12(1):67-69
pubmed: 36793985
Int J Med Robot. 2023 Feb;19(1):e2477
pubmed: 36315465
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Ann Cardiothorac Surg. 2023 Jan 31;12(1):41-45
pubmed: 36793990
Eur J Cardiothorac Surg. 2022 Aug 3;62(3):
pubmed: 35951763
J Thorac Dis. 2019 Jan;11(1):231-239
pubmed: 30863593
Ann Cardiothorac Surg. 2023 Jan 31;12(1):9-22
pubmed: 36793981
Ann Cardiothorac Surg. 2023 Mar 31;12(2):139-141
pubmed: 37035645
Ann Cardiothorac Surg. 2023 Jan 31;12(1):70-72
pubmed: 36793989